3Dプリンティング医薬品市場：技術、投与形態、用途、エンドユーザー別-2024-2030年の世界予測

3Dプリンティング医薬品市場規模は、2023年に2億9,272万米ドルと推定され、2024年には3億3,122万米ドルに達し、CAGR 14.26％で2030年には7億4,429万米ドルに達すると予測されています。

3Dプリンティング医薬品は、ドラッグデリバリーのメカニズムを改善した医薬品を製造するための3Dプリンティング技術の新たな利用について言及しています。医薬品の3Dプリンティングは、医薬品製造における個別化、精密化、コスト効率化を可能にします。3Dプリンティング医薬品の普及は製薬業界に変革をもたらし、希望する形状、サイズ、投与量、送達速度で医薬品を設計することを可能にし、患者に個別化ヘルスケアを提供します。創薬・開発活動の増加と個別化医療への傾倒により、薬剤の3Dプリンティングのような高度な薬剤製造技術の必要性が高まっています。しかし、3Dプリンティング技術の初期コストは高く、3Dプリンティング医薬品の生産に悪影響を及ぼす可能性があります。さらに、3Dプリンティング技術の技術的進歩により、医薬品の生産効率が向上し、医薬品開発への利用が拡大することが期待されます。

テクノロジー直接描画技術は個別化された効果的な投薬ソリューションを提供する

3Dプリンティング医薬品における直接描画技術とは、精密な成膜方法を用いて、制御された構造と組成を持つ医薬品を作り出すことです。このアプローチにより、医薬品製剤のカスタマイズが可能になり、個別化医療やより効果的なドラッグデリバリーが実現します。広く使われている3Dプリンティング技術である溶融積層造形法（FDM）も、3Dプリンティング医薬品の開発に製薬業界で応用されています。インクジェットプリンティング技術は、医薬品を3Dプリントするために製薬業界で応用されており、医薬品材料を蒸着するための精密で制御された方法を提供しています。粉末床印刷技術は、カスタマイズされ制御されたドラッグデリバリーシステムを作成するために、製薬業界で有望視されています。薬剤の3Dプリントにステレオリソグラフィ技術を使用することで、正確な投与量を持つカスタム放出制御型医薬品の作成が期待できます。

投与形態：カプセル型3Dプリンティング医薬品の採用の可能性

3Dプリンティングにより、患者に合わせた投与量を作成できるため、治療計画を最適化できる可能性があります。カプセルは複数のコンパートメントを3Dプリンティングすることができ、それぞれに異なる薬物や投与量が含まれるため、併用療法が容易になります。ナノスケールでの3Dプリンティングにより、放出特性を制御した薬剤含有ナノ粒子を作製でき、ドラッグデリバリーを最適化できます。3Dプリンティングは、有効な医薬品成分をナノ粒子内にカプセル化し、劣化から保護して安定性を確保することができます。3Dプリンティングで製造された錠剤は、個々の患者のニーズに合わせてカスタマイズできるため、投与量や治療計画を個別に設定できます。3Dプリンティングは、多孔質構造や多層設計などの複雑な形状を持つ錠剤の作成を可能にし、薬物放出動態に影響を与えます。

アプリケーション神経治療薬の製造に利用拡大中

3Dプリンティング医薬品は、カスタマイズされたアライナー、義歯、クラウンなどのパーソナライズされたソリューションを提供することにより、歯科医療に革命をもたらします。カスタマイズされたドラッグデリバリーシステムは、歯周病などの症状に対する正確な薬物放出を可能にします。この技術は、副作用を最小限に抑えながら治療効果を高めます。歯科インプラントでは、3Dプリンティングによって薬剤を充填したスキャフォールドの作製が容易になり、治癒が早まり、感染症のリスクが低減します。神経学では、3Dプリンティング医薬品は神経疾患の治療法を調整する上で極めて重要です。患者に特化した薬剤製剤により正確な投与が可能になり、てんかんや神経変性疾患などの治療成績が向上します。3Dプリンティングは、患者固有の薬剤やインプラントの製造を可能にすることで、整形外科医療を変革します。整形外科のドラッグデリバリーでは、3Dプリンティングによって、患者のニーズに合わせた個別化された剤形の開発が可能になります。さらに、薬剤を組み込んだ3Dプリントインプラントは、治癒プロセスを強化し、炎症に対処して骨の再生を促進するために制御された局所的な薬剤放出を提供します。

エンドユーザー：診療所と病院における3Dプリンティング医薬品の浸透度

クリニックや病院では、医療専門家が個別化された薬剤を提供することに注力しており、特定の患者のニーズに合わせた3Dプリンティング医薬品が好まれています。このような3Dプリンティング医薬品は、治療の効果を高め、従来の大量生産された薬にありがちなリスクや副作用を軽減するため、好まれています。研究室では、3Dプリンティング医薬品の精密さと正確さを大いに活用しています。3Dプリンティング医薬品によって、研究者は薬物相互作用や薬効に関する具体的な調査や厳密な研究を行うことができます。個別化医療を中心とした専門クリニックなどでは、3Dプリンティング医薬品を活用し、患者独自のニーズに応えるケースが増えています。個別化された薬物療法は、それぞれの患者固有の生理学に合わせて薬物療法を行うことができるため、患者のコンプライアンスと治療効率を高めることができます。診療所や病院、特別なクリニックでは、患者の治療プロトコルを強化するために3Dプリンティング医薬品が広く採用されており、一方、研究所では、医療技術革新や薬物検査に役立つ具体的なメリットに焦点が当てられています。

地域別インサイト

南北アメリカは、医療研究開発の進展、堅調な製薬業界、主要3Dプリント医薬品メーカーの存在により、3Dプリント医薬品市場で重要な地位を占めています。技術進歩の高まりとヘルスケアインフラの強化が、この地域の市場展望をさらに前進させています。欧州では、高齢者人口の増加、個別化医療への取り組み、政府の支援的規制、政府および主要メーカーによる資金提供活動によって、3Dプリンティング医薬品の重要な市場が観察されています。中東・アフリカでは、技術導入とヘルスケアインフラ強化への投資が増加しており、市場成長に寄与しています。アジア太平洋地域は、3Dプリンティング医薬品市場において勃興期を迎えており、急速な都市化、ヘルスケア技術の革新、医療費の増加、オーダーメイドの薬物療法を必要とする高齢者人口の増加などの要因によって大きな成長の可能性を示しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは3Dプリンティング医薬品市場の評価において極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、3Dプリンティング医薬品市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.3Dプリンティング医薬品市場の市場規模および予測は？

2.3Dプリンティング医薬品市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.3Dプリンティング医薬品市場の技術動向と規制枠組みは？

4.3Dプリンティング医薬品市場における主要ベンダーの市場シェアは？

5.3Dプリンティング医薬品市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 即効性薬剤の需要急増
    • パーソナライズ医薬品の採用拡大と複合医薬品の生産
    • がん治療薬の製造に3Dプリント技術を幅広く活用
  • 抑制要因
    • 3Dプリンティング医薬品の製造に関連する材料の制限
  • 機会
    • 3Dプリント技術の継続的な技術開発
    • 3Dプリント医薬品の製造への多額の投資
  • 課題
    • 3Dプリンティング医薬品の製造における複雑さ
• 市場セグメンテーション分析
  • テクノロジー：直接書き込み技術により、パーソナライズされた効果的な投薬ソリューションを提供
  • 投与形態：カプセルの形で3Dプリンティング医薬品を採用する可能性
  • 用途：神経系医薬品の製造における用途拡大
  • エンドユーザー：クリニックや病院での3Dプリンティング医薬品の浸透率が高い
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 3Dプリンティング医薬品市場：技術別

• 直接書き込み
• 熱溶解積層法
• インクジェット印刷
• パウダーベッド印刷
• ステレオリソグラフィー
• ジップドーズ

第7章 3Dプリンティング医薬品市場投与形態別

• カプセル
• ナノ粒子
• タブレット

第8章 3Dプリンティング医薬品市場：用途別

• 歯科
• 神経学
• 整形外科

第9章 3Dプリンティング医薬品市場：エンドユーザー別

• クリニックと病院
• 調査室
• 専門クリニック

第10章 南北アメリカの3Dプリンティング医薬品市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の3Dプリンティング医薬品市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの3Dプリンティング医薬品市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • CurifyLabs、パーソナライズ医療向け3Dプリントソリューションを発表
  • CellinkとCarcinotechが提携し、3Dバイオプリンティングでがん治療薬開発を変革
  • Triastek社、潰瘍性大腸炎の治療薬として3Dプリント医薬品のFDA IND承認を取得
• 戦略分析と提言

第14章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. 3D PRINTED DRUGS MARKET RESEARCH PROCESS
• FIGURE 2. 3D PRINTED DRUGS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. 3D PRINTED DRUGS MARKET DYNAMICS
• FIGURE 7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. 3D PRINTED DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. 3D PRINTED DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. 3D PRINTED DRUGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NANOPARTICLES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TABLET, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DENTAL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DENTAL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 46. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 47. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 48. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 49. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 50. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 51. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 52. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 53. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 54. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 55. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 56. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 57. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 58. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 59. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 60. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 61. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 62. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 63. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 64. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 65. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 66. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 67. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 68. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 69. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 70. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 71. CANADA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 72. CANADA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 73. CANADA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 74. CANADA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 75. CANADA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 76. CANADA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 77. CANADA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 78. CANADA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 79. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 80. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 81. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 82. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 83. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 84. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 85. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 86. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 87. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 88. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 89. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 90. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 91. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 92. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 93. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 94. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 95. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 96. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 97. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 98. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 99. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 100. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 101. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 102. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 104. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 105. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 106. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 107. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 108. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 109. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 110. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 111. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 112. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 113. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 114. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 115. CHINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 116. CHINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 117. CHINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 118. CHINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 119. CHINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 120. CHINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 121. CHINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 122. CHINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 123. INDIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 124. INDIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 125. INDIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 126. INDIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 127. INDIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 128. INDIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 129. INDIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 130. INDIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 131. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 132. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 133. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 134. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 135. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 136. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 137. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 138. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 139. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 140. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 141. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 142. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 143. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 144. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 145. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 146. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 147. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 148. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 149. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 150. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 151. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 152. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 153. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 154. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 155. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 156. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 157. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 158. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 159. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 160. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 161. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 162. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 163. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 164. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 165. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 166. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 167. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 168. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 169. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 170. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 171. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 172. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 173. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 174. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 175. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 176. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 177. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 178. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 179. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 180. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 181. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 182. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 183. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 184. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 185. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 186. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 187. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 188. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 189. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 190. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 191. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 192. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 193. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 194. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 195. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 196. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 197. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 198. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 199. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 200. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 201. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 202. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 203. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 204. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 205. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 206. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 207. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 208. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 209. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 210. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 211. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 212. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 213. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 214. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 215. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 216. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 217. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 218. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 219. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 220. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 221. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 222. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 223. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 224. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 225. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 226. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 227. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 228. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 229. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 230. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 231. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 232. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 233. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 234. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 235. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 236. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 237. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 238. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 239. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 240. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 241. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 242. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 243. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 244. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 245. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 246. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 247. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 248. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 249. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 250. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 251. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 252. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 253. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 254. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 255. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 256. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 257. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 258. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 259. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 260. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 261. ITALY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 262. ITALY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 263. ITALY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 264. ITALY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 265. ITALY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 266. ITALY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 267. ITALY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 268. ITALY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 269. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 270. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 271. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 272. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 273. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 274. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 275. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 276. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 277. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 278. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 279. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 280. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 281. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 282. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 283. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 284. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 285. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 286. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 287. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 288. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 289. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 290. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 291. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 292. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 293. POLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 294. POLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 295. POLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 296. POLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 297. POLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 298. POLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 299. POLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 300. POLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 301. QATAR 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 302. QATAR 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 303. QATAR 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 304. QATAR 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 305. QATAR 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 306. QATAR 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 307. QATAR 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 308. QATAR 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 309. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 310. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 311. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 312. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 313. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 314. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 315. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 316. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 317. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 318. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 319. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 320. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 321. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 322. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 323. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 324. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 325. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 326. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 327. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 328. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 329. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 330. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 331. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 332. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 333. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 334. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 335. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 336. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 337. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 338. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 339. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 340. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 341. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 342. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 343. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 344. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 345. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 346. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 347. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 348. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 349. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 350. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 351. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 352. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 353. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 354. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 355. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 356. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 357. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 358. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 359. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
• TABLE 360. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
• TABLE 361. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 362. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 363. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 364. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 365. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 366. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 367. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)

TABLE 3

[198 Pages Report] The 3D Printed Drugs Market size was estimated at USD 292.72 million in 2023 and expected to reach USD 331.22 million in 2024, at a CAGR 14.26% to reach USD 744.29 million by 2030.

3D printed drugs refer to the emerging use of 3D printing technology to create pharmaceutical products with improved drug delivery mechanisms. 3D printing of drugs enables personalization, precision, and cost-efficiency in drug manufacturing. The proliferation of 3D printed drugs is transforming the pharmaceutical industry, enabling the design of medications in any desired shape, size, dose, and delivery rate, delivering personalized healthcare for patients. Increased drug discovery and development activities and an inclination towards a personalized medicines approach are raising the need for advanced drug manufacturing techniques such as 3D printing of drugs. However, the high upfront cost of 3D printing technology may adversely impact the production of 3D printed drugs. Moreover, technological advancements in 3D printing technology are expected to enhance drug production efficiency, which is anticipated to expand its use for the development of drugs.

Technology: Direct-write technology provides personalized and effective medication solutions

Direct-write technology in the context of 3D printed drugs involves using precise deposition methods to create pharmaceutical products with controlled structures and compositions. This approach allows for the customization of drug formulations, enabling personalized medicine and more effective drug delivery. Fused deposition modeling (FDM), a widely used 3D printing technology, has also found application in the pharmaceutical industry to develop 3D-printed drugs. Inkjet printing technology has found applications in the pharmaceutical industry for 3D printing drugs, offering a precise and controlled method for depositing pharmaceutical materials. Powder bed printing technology holds promise in the pharmaceutical industry for creating customized and controlled drug delivery systems. Using stereolithography technology in 3D printing drugs shows promise for creating custom, controlled-release pharmaceuticals with precise dosages.

Dose Form: Potential adoption of 3D printed drugs in the form of capsule

3D printing allows for creating personalized and patient-specific doses, potentially optimizing treatment plans. Capsules can be 3D printed with multiple compartments, each containing a different drug or dosage, facilitating combination therapies. 3D printing at the nanoscale allows for the fabrication of drug-loaded nanoparticles with controlled release properties, optimizing drug delivery. 3D printing can encapsulate active pharmaceutical ingredients within nanoparticles, protecting them from degradation and ensuring stability. Tablets produced through 3D printing can be customized to individual patient needs, allowing for personalized dosages and treatment plans. 3D printing enables the creation of tablets with complex geometries, such as porous structures or multilayered designs, influencing drug release kinetics.

Application: Proliferating use for manufacturing of neurology drugs

3D printed drugs revolutionize dental care by offering personalized solutions such as customized aligners, dentures, and crowns. Customized drug delivery systems enable precise medication release for conditions such as periodontal diseases. This technology enhances treatment efficacy while minimizing side effects. In dental implants, 3D printing facilitates the creation of drug-loaded scaffolds, promoting faster healing and reducing the risk of infections. In neurology, 3D printed drugs are crucial in tailoring treatments for neurological disorders. Patient-specific drug formulations enable precise dosing, enhancing therapeutic outcomes for conditions such as epilepsy and neurodegenerative diseases. 3D printing transforms orthopedic medicine by enabling the fabrication of patient-specific medications and implants. In orthopedic drug delivery, 3D printing allows for development of personalized dosage forms tailored to the patient's needs. Moreover, 3D printed implants with incorporated drugs enhance the healing process, providing controlled and localized drug release to address inflammation and promote bone regeneration.

End-User: Significant penetration of 3D printed drugs in clinics & hospitals

In clinics & hospitals, medical professionals are focusing on delivering personalized medications and prefer 3D printed drugs tailored to meet specific patient needs. These 3D printed drugs are preferred as they increase the effectiveness of treatments and reduce the risks and side effects commonly associated with traditional, mass-produced medications. Research laboratories heavily utilize 3D printed drugs due to their precision and accuracy. 3D printed drugs enable researchers to conduct concrete studies and rigorous research on drug interactions and medicinal effectiveness. Specialty clinics, such as those built around personalized medical treatments, increasingly leverage 3D printed drugs to cater to their unique patient needs. Personalized medication could enhance patient compliance and treatment efficiency since medication could be tailored to each patient's unique physiology. Clinics & hospitals, and special clinics widely adopt 3D printed drugs for enhanced patient treatment protocols, while research laboratories focus on the tangible benefits they provide for medical innovation and drug testing.

Regional Insights

The Americas have a significant landscape in the 3D-printed drugs market owing to progressive medical research and development, the robust pharmaceutical industry, and the presence of key 3D-printed drug manufacturers. Rising technological advancements and enhanced healthcare infrastructure further advance the market landscape in the region. Europe has observed a significant market for 3D printed drugs, driven by a rising geriatric population, initiatives towards personalized medicine, supportive governmental regulations, and funding activities from government and key manufacturers. In the Middle East & Africa, increasing investments in technological adoption and healthcare infrastructure enhancement contribute to market growth. The Asia-Pacific region is witnessing an emerging stage in the 3D printed drugs market and shows significant growth potential driven by factors such as rapid urbanization, innovations in healthcare technologies, increasing healthcare expenditures, and a rising elderly population requiring customized medication.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the 3D Printed Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the 3D Printed Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the 3D Printed Drugs Market, highlighting leading vendors and their innovative profiles. These include 3D Systems, Inc., 3DR HOLDINGS, Anatomics Pty Ltd, Aprecia Pharmaceuticals, LLC, AstraZeneca plc, BioDuro, LLC, Biomedical Modeling Inc., Cycle Pharmaceuticals, Cyfuse Biomedical K.K., EnvisionTEC GmbH, FabRx Ltd., General Electric Company, GlaxoSmithKline Plc, Materialise NV, Merck KGaA, Organovo Holdings Inc., Proto Labs Inc., Renishaw PLC, Rokit Healthcare Inc., Siemens AG, Stratasys Ltd., Triastek, Inc., TVASTA, Yissum, and Zortrax S.A..

Market Segmentation & Coverage

This research report categorizes the 3D Printed Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Technology
  • Direct-Write
  • Fused Deposition Modelling
  • Inkjet Printing
  • Powder Bed Printing
  • Stereolithography
  • Zip Dose

• Dose Form
  • Capsule
  • Nanoparticles
  • Tablet

• Application
  • Dental
  • Neurology
  • Orthopedic

• End-User
  • Clinics & Hospitals
  • Research Laboratories
  • Speciality Clinics

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the 3D Printed Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the 3D Printed Drugs Market?

3. What are the technology trends and regulatory frameworks in the 3D Printed Drugs Market?

4. What is the market share of the leading vendors in the 3D Printed Drugs Market?

5. Which modes and strategic moves are suitable for entering the 3D Printed Drugs Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Surge in demand for instantaneous soluble drugs
    • 5.1.1.2. Growing adoption of personalized drugs and the production of combination medicine
    • 5.1.1.3. Extensive use of 3D printed technology for manufacturing cancer drugs
  • 5.1.2. Restraints
    • 5.1.2.1. Material limitations associated with manufacturing of 3D printed drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Constant technological developments in 3D printing technique
    • 5.1.3.2. Significant investments for manufacturing of 3D printed pharmaceuticals
  • 5.1.4. Challenges
    • 5.1.4.1. Complexities in manufacturing of 3D printed drugs
• 5.2. Market Segmentation Analysis
  • 5.2.1. Technology: Direct-write technology provides personalized and effective medication solutions
  • 5.2.2. Dose Form: Potential adoption of 3D printed drugs in the form of capsule
  • 5.2.3. Application: Proliferating use for manufacturing of neurology drugs
  • 5.2.4. End-User: Significant penetration of 3D printed drugs in clinics & hospitals
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. 3D Printed Drugs Market, by Technology

• 6.1. Introduction
• 6.2. Direct-Write
• 6.3. Fused Deposition Modelling
• 6.4. Inkjet Printing
• 6.5. Powder Bed Printing
• 6.6. Stereolithography
• 6.7. Zip Dose

7. 3D Printed Drugs Market, by Dose Form

• 7.1. Introduction
• 7.2. Capsule
• 7.3. Nanoparticles
• 7.4. Tablet

8. 3D Printed Drugs Market, by Application

• 8.1. Introduction
• 8.2. Dental
• 8.3. Neurology
• 8.4. Orthopedic

9. 3D Printed Drugs Market, by End-User

• 9.1. Introduction
• 9.2. Clinics & Hospitals
• 9.3. Research Laboratories
• 9.4. Speciality Clinics

10. Americas 3D Printed Drugs Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific 3D Printed Drugs Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa 3D Printed Drugs Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. CurifyLabs Launches 3D Printing Solution For Personalised Medicine
  • 13.3.2. Cellink And Carcinotech Partner To Transform Cancer Drug Development With 3d Bioprinting
  • 13.3.3. Triastek Receives FDA IND Clearance for 3D Printed Medicine for the Treatment of Ulcerative Colitis
• 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio